Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Return on Capital Employed: 2009-2021

Historic Return on Capital Employed for Avadel Pharmaceuticals (AVDL) over the last 10 years, with Dec 2021 value amounting to -0.36%.

  • Avadel Pharmaceuticals' Return on Capital Employed fell 38.00% to -0.36% in Q4 2021 from the same period last year, while for Dec 2021 it was -0.36%, marking a year-over-year decrease of 38.00%. This contributed to the annual value of -0.33% for FY2021, which is 36.00% down from last year.
  • Avadel Pharmaceuticals' Return on Capital Employed amounted to -0.36% in Q4 2021, which was down 21.60% from -0.30% recorded in Q3 2021.
  • Avadel Pharmaceuticals' 5-year Return on Capital Employed high stood at 0.65% for Q3 2017, and its period low was -0.75% during Q2 2019.
  • In the last 3 years, Avadel Pharmaceuticals' Return on Capital Employed had a median value of -0.22% in 2019 and averaged -0.27%.
  • Per our database at Business Quant, Avadel Pharmaceuticals' Return on Capital Employed plummeted by 105bps in 2018 and then soared by 84bps in 2020.
  • Avadel Pharmaceuticals' Return on Capital Employed (Quarterly) stood at 0.50% in 2017, then plummeted by 105bps to -0.55% in 2018, then skyrocketed by 34bps to -0.20% in 2019, then increased by 22bps to 0.02% in 2020, then crashed by 38bps to -0.36% in 2021.
  • Its last three reported values are -0.36% in Q4 2021, -0.30% for Q3 2021, and -0.24% during Q2 2021.